Europe Platelet Rich Plasma (prp) Market Size & Outlook
Related Markets
Europe platelet rich plasma (prp) market highlights
- The Europe platelet rich plasma (prp) market generated a revenue of USD 159.3 million in 2023.
- The market is expected to grow at a CAGR of 16% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 159.3 million |
| Market revenue in 2030 | USD 450.4 million |
| Growth rate | 16% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.6% of the global platelet rich plasma (prp) market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 399.9 million by 2030.
Pure prp was the largest segment with a revenue share of 51.73% in 2023. Horizon Databook has segmented the Europe platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is the second-largest PRP market globally and is anticipated to witness promising growth during the forecast period. This can be attributed to the rising demand for PRP therapy for sports injuries. In addition, expanding applications of PRP therapy, rapid technological advancements, and progressive demographic aging of the older population contribute to the market growth in Europe.
PRP therapy is regulated under Directive 2001/83/EC of the Council of November 6, 2001, and the European Parliament across the EU. This directive is further adapted by each member as per their regulatory framework. In some European countries, PRP products are considered blood derivatives, as the directive has not been translated into national law across Europe.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe platelet rich plasma (prp) market size, by country, 2018-2030 (US$M)
Europe Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
